Sign in
4

Changes in Ownership

CRESCENT BIOPHARMA, INC. Filed Acc 0001209191-14-042809

President, CEO acquired 100,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

King Rachel K. · President, CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2014-06-18 Exercise or conversion : show line 1 in the form +100,000 $1.12 $112,000 108,706 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2014-06-18 Exercise or conversion : show line 2 in the form Employee Stock Option (right to buy) −100,000 347,580 D
Loading xslF345X03/doc4.xml…